A free Breakfast Briefing for Manufacturing / Engineering companies will take place in the Newpark Hotel, 8am to 10am, on Thursday 19th June, 2025. Read more
The ORESS (Offshore Renewable Electricity Support Scheme) Auction Timetable for Tonn Nua has been published by Eirgrid. The timetable outlines that submission closing date will be 20th Nov 2025 and that the preferred bidder will be known by 9th December 2025. Read more
A selection of Ireland South East tech companies feature in this year’s Ireland’s Best Workplaces in Tech™ list. Read more
Waterford’s North Quays transformation is continuing as the new Sustainable Transport Bridge is now ready for installation. The bridge, a centrepiece of the North Quays Public Infrastructure Project, will provide a connection between Waterford’s city centre and the new North Quays development.
Enterprise Ireland’s new Founders Listening Tour initiative will take place on the morning of May 27th, at GreenTech HQ. This is a key part of EI’s next phase of consultation, and it is a unique opportunity for start ups and founders to have their say on the needs of the startup ecosystem. Read more
TriviumVet, the innovative Irish veterinary research and development company, has been acquired by U.S.-based PBI-Gordon Corporation, in a landmark deal that underscores Ireland’s growing reputation as a hub for world-class life sciences innovation. Read more
Supplement Certified Ltd, a spinout from the Nutrition Research Centre Ireland at South East Technological University (SETU), has secured substantial public and private investment to accelerate its growth and international expansion.
Waterford City and County Council has granted planning permission to Harcourt Developments (t/a Hopcast Limited) for the development of the first phase of the Waterford North Quays Strategic Development Zone (SDZ). Read more
Enterprise Ireland is investing €1m in a new business advancement programme to help companies scale in the South East and to create jobs growth in participating companies. Read more
TriviumVet’s felycin®-CA1 has been granted conditional approval by the U.S. Food and Drug Administration (FDA) marking a significant milestone for the Waterford company and in feline cardiac care. Read more